These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11846638)

  • 1. The use of mechanistic data and the handling of scientific uncertainty in carcinogen risk assessments. The trichloroethylene example.
    Rudén C
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):80-94. PubMed ID: 11846638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use and evaluation of primary data in 29 trichloroethylene carcinogen risk assessments.
    Rudén C
    Regul Toxicol Pharmacol; 2001 Aug; 34(1):3-16. PubMed ID: 11502152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scrutinizing ACGIH risk assessments: the trichloroethylene case.
    Rudén C
    Am J Ind Med; 2003 Aug; 44(2):207-13. PubMed ID: 12874854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
    Bogen KT; Gold LS
    Regul Toxicol Pharmacol; 1997 Feb; 25(1):26-42. PubMed ID: 9056499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perils and promise of modern risk assessment: the example of trichloroethylene.
    Kester JE; Clewell HJ
    Clin Occup Environ Med; 2004 Aug; 4(3):497-512, vi-vii. PubMed ID: 15325318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretations of primary carcinogenicity data in 29 trichloroethylene risk assessments.
    Rudén C
    Toxicology; 2001 Dec; 169(3):209-25. PubMed ID: 11718961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Science and policy in risk assessments of chlorinated ethenes.
    Rudén C
    Ann N Y Acad Sci; 2006 Sep; 1076():191-206. PubMed ID: 17119203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acrylamide and cancer risk--expert risk assessments and the public debate.
    Rudén C
    Food Chem Toxicol; 2004 Mar; 42(3):335-49. PubMed ID: 14871575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal carcinogenicity of trichloroethylene: update, mode of action, and fundamentals for occupational standard setting.
    Harth V; Brüning T; Bolt HM
    Rev Environ Health; 2005; 20(2):103-18. PubMed ID: 16121833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control study on renal cell cancer and occupational exposure to trichloroethylene. Part II: Epidemiological aspects.
    Charbotel B; Fevotte J; Hours M; Martin JL; Bergeret A
    Ann Occup Hyg; 2006 Nov; 50(8):777-87. PubMed ID: 16840435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposed methodology for selecting a trichloroethylene inhalation unit risk value for use in risk assessment.
    Lewandowski TA; Rhomberg LR
    Regul Toxicol Pharmacol; 2005 Feb; 41(1):39-54. PubMed ID: 15649826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difficulty of mode of action determination for trichloroethylene: An example of complex interactions of metabolites and other chemical exposures.
    Caldwell JC; Keshava N; Evans MV
    Environ Mol Mutagen; 2008 Mar; 49(2):142-54. PubMed ID: 17973308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles and practices of health risk assessment under current EU regulations.
    Rudén C
    Regul Toxicol Pharmacol; 2006 Feb; 44(1):14-23. PubMed ID: 16188358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Science and transscience in carcinogen risk assessment--the European Union regulatory process for trichloroethylene.
    Rudén C
    J Toxicol Environ Health B Crit Rev; 2003; 6(3):257-77. PubMed ID: 12746141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health risk assessment.
    Abelson PH
    Regul Toxicol Pharmacol; 1993 Apr; 17(2 Pt 1):219-23. PubMed ID: 8484029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scrutinizing three trichloroethylene carcinogenicity classifications in the European Union--implications for the risk assessment process.
    Rudén C
    Int J Toxicol; 2002; 21(6):441-50. PubMed ID: 12537640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of renal cell transformation following exposure to trichloroethene in vivo and its metabolite S-(dichlorovinyl)-L-cysteine in vitro.
    Mally A; Walker CL; Everitt JI; Dekant W; Vamvakas S
    Toxicology; 2006 Jul; 224(1-2):108-18. PubMed ID: 16730402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Am J Ind Med 44:204-213, 2003. Scrutinizing ACGIH risk assessments: the trichloroethylene case.
    Wells VL
    Am J Ind Med; 2005 May; 47(5):463; author reply 464-6. PubMed ID: 15828072
    [No Abstract]   [Full Text] [Related]  

  • 20. [Renal cell carcinoma and exposure to trichloroethylene: are the French limits of occupational exposure relevant?].
    Charbotel B; Fevotte J; Martin JL; Bergeret A
    Rev Epidemiol Sante Publique; 2009 Feb; 57(1):41-7. PubMed ID: 19155150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.